Research.Patient.info
Embolic Stroke of Undetermined Source research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE2, PHASE3
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
This study investigates if empagliflozin, a diabetes drug, can prevent heart rhythm problems (atrial fibrillation) in people who've had a stroke with no clear cause. It uses advanced scans and monitoring to see how the drug affects the heart's upper chambers.
United Kingdom - recruiting
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
This study compares a special kind of stent, called the CARESTO® heal Stent, with standard medical care for people who have early-stage carotid artery disease. It looks at whether the stent can better prevent future strokes, especially for those with tricky plaque in their neck arteries.
Germany